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a b s t r a c t
Objective: Receptor activator of nuclear factor-kB (RANK), RANK ligand (RANKL) and osteo-
protegerin (OPG) are members of the superfamily of ligands and receptors of tumour
necrosis factor family involved in bone metabolism. The formation, differentiation and
activity of osteoclasts are regulated by these proteins. To clarify the roles of osteoclast
regulatory factors in cystic expansion of odontogenic cysts, expression of these proteins
were analysed in radicular and dentigerous cysts.
Design: The immunohistochemistry expression of these biomarkers were evaluated and
measured in lining epithelium and fibrous capsule of the radicular (n = 20) and dentigerous
cysts (n = 20).
Results: A similar expression in lining epithelium was observed in the lesions. The fibrous
capsule of dentigerous cyst showed a higher content of RANK-positive and RANKL-positive
cells than fibrous capsule of radicular cyst. In the lining epithelium the RANKL/OPG ratio
showed higher numbers of OPG-positive than RANKL-positive cells, whereas fibrous capsule
of the cysts had a tendency to present a similar expression (OPG = RANKL).
Conclusion: Ours findings indicate the presence of RANK, RANKL and OPG in cysts. Moreover,
increased expression of OPG compared to RANKL in the lining epithelium could contribute
to the differential bone resorption activity in theses lesions.
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Despite numerous investigations1–5 the precise mechanisms
involved in the formation and enlargement of jaw cysts have
not been completely established. Cyst formation is believed to
be related to the proliferation of epithelial remnants that are
activated by the release of cytokines and growth factors.4,5 The
immunopathological events that trigger the proliferative
activity of epithelial remnants concomitantly induce the* Corresponding author at: Universidade Federal do Rio Grande do No
Lagoa Nova CEP 59056-000, Natal, RN, Brazil. Tel.: +55 84 3215 4138; f
E-mail address: maiaramoraes@gmail.com (M. de Moraes).
0003–9969      #  2011  Elsevier  Ltd.  
doi:10.1016/j.archoralbio.2011.05.009
Open access under the Elsevier OA license.secretion of bone resorption factors.3,6 However, how these
events are involved in the formation of cystic cavities and
resorption of adjacent bone continues to be a matter of
numerous researches. In this respect, altered expression of
bone metabolism-related factors may favour an increase in
osteolytic activity and the consequent cystic expansion into
adjacent bone tissue.
Odontogenic cysts are one of the most common osseous-
destructive lesions affecting the jaws.7,8 They are classified
traditionally into a developmental group, including dentigerousrte, Departamento de Odontologia, Av. Senador Salgado Filho, 1787,
ax: +55 84 3215 4138.
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residual cysts.4,7,8 Developmental cysts are of unknown origin,
but do not appear to result from an inflammatory process. On
other hand, the inflammatory cysts, as their name implies, are
associated with inflammation.8 Both radicular and dentigerous
cysts can show a range from little to quite extensive primary/
secondary inflammation4 and it is possible that the variation
seen in the fibrous capsule of these cysts might reflect
differences in the osteolytic activity. Moreover, the presence
of hemorrhagic areas in the fibrous capsule of dentigerous cyst
could also contribute to the increase of osteolytic activity.
Recent studies suggest an important role of receptor
activator of nuclear factor-kB (RANK), RANK ligand (RANKL)
and osteoprotegerin (OPG) in the pathogenesis of oral lesions
characterised by bone resorption.9–17 Most of the bone diseases
are caused by a disturbance in the number and activity of
osteoclastic cells, resulting in improper bone resorption which
exceeds the compensatory capacity of osteoblasts.18,19 In-
creased osteoclast activity is seen in many osteopenic disorders
such as postmenopausal osteoporosis, Paget’s disease, bone
metastases and rheumatoid arthritis.6,17,19,20
RANK, RANKL and OPG are key regulators in osteoclast
biology and bone metabolism.21,22 RANKL interacts with its
receptor RANK located on osteoclast precursors and dendritic
cells, and activates c-Jun, NFkb pathways that are related to
the process of differentiation, proliferation and activation of
osteoclasts.18 The effects of RANKL are blocked by soluble
decoy receptors such as OPG that competes with RANK for
binding to RANKL.18,19,21 In vitro and in vivo studies have
shown that RANK/RANKL/OPG are essential for the life of
osteoclasts and, as mediators of bone diseases, are important
molecular targets for diagnosis and therapeutic interven-
tion.18,22 Thus, the aim of this study was to evaluate and
compare the immunohistochemical expression of RANK,
RANKL and OPG in radicular (RC) and dentigerous cyst (DC).
2. Materials and methods
2.1. Samples
The original haematoxylin and eosin (H&E)-stained slides and
formalin-fixed paraffin-embedded specimen blocks of all RC
and DC diagnosed between January 2000 and October 2009,
were retrieved from the files of the Oral Pathology Service at
UFRN, Natal, Brazil from the Department of Histopathology.
The H&E slides were reviewed to confirm the diagnosis. The
tissues removed were classified as cysts whenever a partial or
total epithelium lining was present. The diagnosis of cysts was
based mainly on radiographic and histopathologic examina-
tion. DC intensely inflamed and cysts with inadequate tissue
samples were excluded. A total of 40 cysts were selected for
the study (20 RC and 20 DC). Clinical and radiographic
information, including age, gender, and anatomic site, were
obtained from biopsy forms submitted by the clinicians.
2.2. Immunohistochemistry
For immunohistochemical analysis, 3 mm thick paraffin em-
bedded tissue sections were placed on 3-aminopropyltriethoxy-silane coated glass slides (Sigma Chemical Co., St Louis, MO,
USA). The samples were deparaffinised with xylene, rehydrated
in graded alcohols, and washed in deionised water and
phosphate-buffered saline (PBS). Samples were then incubated
with 3% hydrogen peroxide and immersed in a citrate buffer, pH
6.0 for 20 min. Sections were then blocked by incubation with
3% normal goat serum at room temperature for 20 min, and
slides were incubated at 4 8C, overnight, in a humidified
chamber with the following primary rabbit polyclonal anti-
bodies: anti-OPG (N-20; Santa Cruz Biotechnology, Santa Cruz,
CA) diluted 1:200; anti-RANK (C-20; Santa Cruz Biotechnology,
Santa Cruz, CA) diluted 1:200; and anti-RANKL (N-19; Santa Cruz
Biotechnology, Santa Cruz, CA) diluted 1:200. After washing in
TBS (tris-buffered saline), the sections were treated with a
labelled streptavidin-biotin kit (LSAB; Dako, Glostrup,
Denmark). Peroxidase activity was visualised by immersing
tissue sections in 3,30-diaminobenzidine (D5637; Sigma Chemi-
cal, St. Louis, MO) and counterstained with Mayer’s haematox-
ylin. A central giant cell granuloma was used as positive
control.9 Negative controls were obtained by the omission of
primary antibodies and substitution of primary antibodies by
nonimmune rabbit serum (X0902; Dako).
2.3. Cell counting
Immunoexpression of RANK, RANKL and OPG was evaluated
in lining epithelium and fibrous capsule. The epithelial
immunoexpression was semiquantitatively evaluated by
two observers, using 400 magnification and classified
according to the scores: 0 or no staining (<10% of positive
immunostaining cells), 1 or weak (11–25%), 2 or moderate (26–
75%) and 3 or strong (>76%).23 In fibrous capsule, the analysis
was quantitative and the number of positive cells was counted
in 10 representative and consecutive microscopic high-power
fields (1000) over totally counted cells,12 irrespectively of cell
type. Digital images were loaded on the software IMAGE J1
(National Institutes of Health, Bethesda, Maryland, USA)24 to
count the number of immunostained cells. Results are
expressed as the mean percentage of observations per field,
with the following modifications. Based on this mean
percentage, gave up a score for each case, taking into account
the standard scoring system used for the lining epithelium:
score 0 (<10% immunostained cells), 1 or weak (11–25% of
cells), 2 or moderate (26–75% of cells) and 3 or strong (more
than 76% of cells). These counting procedures were performed
for the three biomarkers in both lesions.
2.4. Statistical analysis
Comparative analysis of data was perfomed using the
nonparametric Wilcoxon signed rank test and Mann–Whitney
U test. Statistical significance was set at p  0.05.
3. Results
3.1. Clinical, radiographic and histological findings
In this study, there were 20 cases of RC and 20 cases of DC, with
mean ages of 32.5  13.67; 24.79  12.35 years, respectively.
Fig. 1 – Representative immunohistochemical reactivity for
OPG in epithelium of radicular cyst. Epithelial cells in a
stellate shape (arrow-head) exhibited positive cytoplasmic
reactivity (1000T).
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preponderance in DC. RC was more commonly located in the
anterior maxilla and DC in the posterior mandible. All samples
were described as a well circumscribed unilocular radiolucen-
cy. Histological appearance of the cysts revealed the presence
of a hyperplastic epithelium and an inflammatory infiltrate,
which was moderate to intense in the most RC. DC showed an
atrophic epithelium, quite hemorrhagic areas and scarce
infiltrate in the most cases.
3.2. Qualitative and semi-quantitative analysis of lining
epithelium
Immunohistochemical reactivity for RANK, RANKL and OPG
was detected in the nuclei and cytoplasm of epithelial cells.
Additionally, epithelial cells displaying a stellate shape
exhibited positive cytoplasmic reactivity for RANK, RANKL
and OPG (Fig. 1) likely indicating changes in cell–cell interac-
tions such as the accumulation of extracellular fluid or everTable 1 – Parameters used for calculation of the Mann–
Whitney U test for the evaluation of the scores of cells
immunostained by RANK, RANKL, and OPG in the lining
epithelium, according to the lesion type.
Marker Lesion
type
n Median Mean of
ranks
U P value
RANK RC 20 2 19.55 181 0.589
DC 20 2 21.45
RANKL RC 20 1.5 21.2 186 0.688
DC 20 1 19.8
OPG RC 20 2 19.85 187 0.709
DC 20 2 21.15
RC, radicular cyst; DC, dentigerous cyst.the loss of cell adhesion molecules. RANKL appears positive in
the nuclei and cytoplasm of suprabasal epithelial cells in
Fig. 2A. OPG appears positive in the nuclei and cytoplasm of
basal and suprabasal epithelial cells in Fig. 2B. RANKL and OPG
appears in the cytoplasm of epithelial cells in Fig. 2C and D,
respectively.
The analyses of the immunoreactivity of RANK, RANKL and
OPG according to percentage of the scores in the epithelium
are shown in Fig. 3. No differences were observed in cell
reactivity in the lining epithelium of the cysts ( p > 0.05, Table
1). A similar expression of RANK, RANKL and OPG was
observed.
In addition, significant differences were observed in the
distribution of cases with respect to OPG and RANKL ranks of
immunostaining scores in the lining epithelium. We observed
that most of the cases of RC (55%) and DC (70%) exhibited a
higher content of OPG than RANKL ( p < 0.05, Table 2).
3.3. Qualitative and quantitative analysis of fibrous
capsule
With regard to reactivity for RANK, RANKL, and OPG in the
stromal cells, the presence of positive fibroblasts-like, endo-
thelial-like (Fig. 4A), polymorphonuclear neutrophil-like
(Fig. 4B), plasmacyte-like, lymphocytes-like and macro-
phage-like cells (Fig. 4C and D) was observed. The immunore-
activity was predominantly in the cytoplasm. Additionally, the
RANKL and OPG expression was observed in nests of
odontogenic epithelial cells (Fig. 5).
Table 3 summarises the quantitative analysis of lesions
immunostained for RANK, RANKL and OPG in fibrous capsule.
Statistically differences were observed in cell reactivity for
RANK and RANKL between the cysts (Table 4). A mean
percentage demonstrated an expression of RANK-positive and
RANKL-positive cells higher in DC when compared with RC
( p = 0.001 and p = 0.005 for RANK and RANKL, respectively).
Fig. 6 summarises the distribution of cases of RC and DC
according to percentage of the scores for RANK, RANKL and
OPG in fibrous capsule. No differences were observed in the
distribution of cases with respect to OPG and RANKL ranks of
immunostaining scores ( p > 0.05). Many cases of DC and the
RC showed a tendency to present a similar pattern of
expression for RANKL and OPG (Table 2). There was a
predominance of moderate immunostaining for all cases.
No positive staining was observed when primary anti-
bodies were omitted. Positive control samples showed strong
reactivity.
4. Discussion
In the present study, we have examined the immunoexpres-
sion to RANK, RANKL and OPG in radicular and dentigerous
cysts. The main types of cells that expressed immunoreactivi-
ty were those showing characteristics of the monocyte–
macrophage lineage, fibroblasts, and lymphocytes as also
reported by other investigators.9,12,22,25 Additionally, we
observed other types of immunostained cells exhibited
microscopic features of endothelial cells, neutrophils and
plasma cells in agreement with other studies.9,14,16
Fig. 2 – (A) Moderate reactivity for RANKL in epithelium of radicular cyst. RANKL appears positive in the nuclei of suprabasal
epithelial cells and in the cytoplasm of basal cells (1000T), (B) strong reactivity for OPG in epithelium of radicular cyst
(1000T). OPG appears positive in the nuclei and cytoplasm of epithelial cells, (C) weak reactivity for RANKL in epithelium of
dentigerous cysts (1000T). RANKL appears positive in the cytoplasm of epithelial cells, and (D) moderate reactivity for OPG
in epithelium of dentigerous cysts. OPG appears positive in the nuclei and cytoplasm of epithelial cells (1000T).
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RANKL and OPG in normal human oral mucosa. Strong
cytoplasmic immunostaining of RANKL limited to epithelial
cells of the basal layer has been noted. In contrast, there was a
complete absence of immunostaining of RANK and OPG in all
tissue of normal oral mucosa. In our study the epithelial lining
of cysts exhibit immunostaining for RANK, RANKL and OPG in
cells of the basal and suprabasal layer.Table 2 – Distribution of cases in relation to OPG and RANKL r
capsule.
Type of lesion Ranks
OPG < RANKL OPG >
RC (n = 20)
Epithelium 1 (5%) 11
Capsule 4 (20%) 6
DC (n = 20)
Epithelium 2 (10%) 14
Capsule 2 (10%) 5
RC, radicular cyst; DC, dentigerous cyst; OPG, osteoprotegerin; RANKL, r
* Non-parametric Wilcoxon signed rank test.Cytoplasmic immunostaining for RANKL and OPG was
also observed in epithelial cells in a stellate shape, similar to
dendritic cells and in nests or strands of odontogenic
epithelial cells scattered in the fibrous capsule of DC.
Dendritic cells in the oral mucosa are antigen-presenting
cells, which play a vital role in the regulation of adaptive
immunity cell. Recently studies26,27 showed that human
dendritic cells can transdifferentiate into osteoclasts in theanks of immunostaining scores in epithelium and fibrous
 RANKL OPG = RANKL P value*
 (55%) 8 (40%) 0.005
 (30%) 10 (50%) 0.527
 (70%) 4 (20%) 0.003
 (25%) 13 (65%) 0.257
eceptor nuclear factor-kB ligand.
Fig. 3 – Distribution of cases of RC and DC according to percentage of the scores for RANK, RANKL and OPG in the epithelium.
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dendritic cells may directly contribute to osteoclastogen-
esis. Loser et al.28 demonstrated that RANKL expression is
inducible on keratinocytes and that this is a molecular
pathway that couples the epidermis to local and systemic
immunosuppression. Moreover, RANKL expression is in-
duced on activated T cells, and RANK expression can beFig. 4 – A Endothelial-like cells (arrows-head) stained with anti
neutrophil-like cells (arrow) stained with anti-RANK in fibrous 
RANKL in fibrous capsule of radicular cyst (1000T), and (D) stro
Lymphocytes-like and macrophage-like cells (arrow-head) stain
stained (1000T).found on dendritic cells, in accordance our results. The
finding of immunoreactivity in nests of odontogenic
epithelial cells agrees with the results of Silva et al.16 The
expression in the nests of odontogenic epithelial cells
suggests that the odontogenic epithelium may actually
induce and initiate the resorption process, perhaps through
synthesising and secreting RANKL and OPG.-OPG in radicular cyst (1000T), (B) polymorphonuclear
capsule of dentigerous cyst (1000T), (C) weak reactivity for
ng reactivity for OPG in fibrous capsule of radicular cyst.
ed with anti-OPG. Predominance of mononuclear cells
Fig. 5 – Nests of odontogenic epithelium (arrow-head)
stained with anti-RANKL in fibrous capsule of dentigerous
cyst (1000T).
Table 4 – Parameters used for calculation of the Mann–
Whitney U test for the evaluation of positive cells
immunostained by RANK, RANKL, OPG in the fibrous
capsule, according to the lesion type.
Marker Lesion
type
n Median Mean
of ranks
U P value
RANK RC 20 26.81 14.45 79 0.001
DC 20 64.67 26.55
RANKL RC 20 28.1 15.3 96 0.005
DC 20 63.05 25.7
OPG RC 20 38.04 17.35 137 0.088
DC 20 63.24 23.65
RC, radicular cyst; DC, dentigerous cyst.
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nostaining in the lining epithelium of RC and DC revealed
larger scores for OPG than RANKL in most specimens, a finding
could be indicating minimal osteoclast activity. In vitro studies
demonstrate that the effects of OPG include inhibition of
differentiation, survival and osteoclast fusion, as well as
stimulation of apoptosis of osteoclasts, thereby reducing the
ability of bone resorption. Moreover, the overexpression of
OPG in mice or administration of OPG to normal rodents
inhibits osteoclastogenesis, osteoclast activation and bone
resorption, resulting in an osteopetrotic phenotype.22,25,29
In cystic lesions, this finding (OPG > RANKL) may suggest a
role of epithelial cells as a barrier in an attempt to restrict
invasion into underlying bone and thus to prevent cystic
expansion. In RC, this higher immunoexpression of OPG in the
epithelium might be related to the abscess theory30 where
inflammatory cells inside granulation tissue secrete RANKL and
surrounding epithelial cells release OPG in response to this
increase in an attempt to restrict cystic expansion. Vernal
et al.17 showed high RANKL levels in granulation tissue of
periapical granulomas. One may suppose a role of these OPG-
positive epithelial cells in the reestablishment of periapical
tissue considering that in most cases of RC endodontic
treatment is sufficient3 to permit regression of the cystic lesion.
Hofbauer22 and Baud’huin et al.31 conducted in vivo
experiments that suggested RANKL to be a pro-resorptionTable 3 – Distribution of immunostained cells for RANK,
RANKL and OPG according to each type of lesion in the
fibrous capsule.
Marker Lesions
RC DC
Mean  SD Median Mean  SD Median
RANK 34.17  24.51 26.81 62.01  22.54 64.67
RANKL 35.73  18.38 28.10 58.20  24.08 63.05
OPG 44.72  22.24 38.04 58.20  24.43 63.24
RC, radicular cyst; DC, dentigerous cyst.factor. According to these authors, an increased expression of
RANKL would be related to increased osteoclast activity, thus
favouring resorption. Although Menezes et al.15 demonstrated
a higher secretion of RANKL under inflammatory conditions,
this increased secretion would not always guide the bone
resorption process since the presence of the inhibitory
receptor OPG would decisively influence the process of bone
expansion and, furthermore, other bone metabolism-related
factors may also be involved in this complex process.
Comparison of the positive cells immunostaining for
RANK, RANKL and OPG in the capsule of RC and DC showed
a larger number of RANK- and RANKL-positive cells in the
capsule of DC compared to the capsule of RC. One may
speculate that this higher immunoexpression observed in the
capsule of DC is related to a greater expansive potential of
these cysts by indicating the presence of a larger number of
osteoclast precursors expressing RANK that are able to
interact with its specific receptors (RANKL), leading to
osteoclast differentiation and maturation. The expression in
nests of odontogenic epithelial cell also may have contributed
to this greatest expression in fibrous capsule of DC.
Moreover, the presence of hemorrhagic areas in the
capsule of DC could be explained by increased vascular
permeability which in turn may reflect the increased expres-
sion of vascular endothelial growth factor (VEGF), which in
previous studies31–33 were also overexpressed in the liningFig. 6 – Distribution of cases of RC and DC according to
percentage of the scores for RANK, RANKL and OPG in
fibrous capsule.
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VEGF up-regulates expression of RANK and increases angio-
genic responses of endothelial cells to RANKL. In addition,
studies demonstrated that VEGF could substitute for macro-
phage colony-stimulating factor in the support of osteoclastic
bone resorption.35,36 VEGF was shown to induce osteoclast
differentiation and enhance survival of mature osteoclasts.36
We observed that factors like the type and intensity of
inflammation and the vascularity should be evaluated in
future studies.
The lack of a significant correlation between RANKL and
OPG in the fibrous capsule of cysts suggests that different
expression patterns of these markers are associated with
different stages of disease progression. Although no signifi-
cant correlation was observed in the present study, there were
cases indicating homeostasis (OPG = RANKL) and cases indi-
cating minimal osteoclast activity (OPG > RANKL). Evaluation
of gene expression kinetics as done by Kawashima et al.37
would be interesting for the analysis of the RANKL/OPG ratio
since it outlines changes in the expression of these markers
during development of the lesion. In this respect, determina-
tion of mean ratios might be inaccurate since the results
obtained only reflect a point in time when the lesions are
already established in the patient.
Although most studies reported an elevated immunoreac-
tivity to RANKL compared to OPG in osteolytic lesions,14,15,17,37
we believe that this RANKL/OPG imbalance may occur during
the early phase of formation of the cystic cavity, which is
difficult to be demonstrated in vivo. Although involvement of
the OPG/RANKL/RANK system is likely to occur at some time
point, no imbalance between these markers that would favour
bone-resorptive activity was observed in the present study.
Although an increased RANKL activity associated with a
reduced regulatory activity of OPG has been reported to play a
role in different diseases such as osteoporosis, arthritis,
periodontal disease, odontogenic cysts and tumours and,
more recently, squamous cell carcinoma,12,14,16–18 the present
results obtained for the epithelium and capsule of RC and DC
are not compatible with these findings. As mentioned earlier,
although a higher RANKL reactivity compared to OPG is
expected in osteolytic lesions, some studies have demonstrat-
ed higher OPG immunoreactivity in these lesions.9,12,16,20 In
agreement with these results, higher or similar OPG expres-
sion when compared to RANKL was observed in most cystic
lesions studied here. Since bone is a dynamic tissue, the
relationships established between these receptors that culmi-
nate in the differentiation and maturation of osteoclasts occur
throughout the development of alterations in the expression
levels of these markers, i.e., throughout cyst formation.
The identification of these biomarkers may indicate their
relationship with the process of osteoclast activation and bone
loss in cyst lesions. Furthermore, increased expression of OPG
compared to RANKL in the lining epithelium may act as a
barrier against the expansion of these lesions in the underly-
ing bone. Moreover, molecular biology studies evaluating the
levels of these markers and their expression kinetics in these
lesions are necessary not only to demonstrate the presence of
these proteins but also to quantify the transcripts in each
lesion. Further studies are also needed to investigate whether
the OPG/RANKL/RANK system is involved in the developmentof cystic lesions in order to better understand the underlying
mechanism and to establish new therapeutic strategies for the
treatment of these lesions that are often highly destructive.
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